Treximet: Difference between revisions
From Pharmacopedia
More actions
| [unchecked revision] | [unchecked revision] |
MDElliottMD (talk | contribs) parser-claude batch MedTemplate pre-fill, mind-medicine combination |
MDElliottMD (talk | contribs) home-claude category backfill (parser-claude gap closure) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 7: | Line 7: | ||
| starting_dose = 1 tablet (85/500 mg sumatriptan/naproxen) PO at migraine onset; may repeat after 2 hours if needed; maximum 2 tablets per 24 hours | | starting_dose = 1 tablet (85/500 mg sumatriptan/naproxen) PO at migraine onset; may repeat after 2 hours if needed; maximum 2 tablets per 24 hours | ||
| preparations = 85 mg sumatriptan / 500 mg naproxen sodium tablets; lower-dose 10/60 mg pediatric (Treximet pediatric) | | preparations = 85 mg sumatriptan / 500 mg naproxen sodium tablets; lower-dose 10/60 mg pediatric (Treximet pediatric) | ||
| fda_max = 2 tablets per 24 hours; ≤4 days per month to avoid | | fda_max = 2 tablets per 24 hours; ≤4 days per month to avoid medicine-overuse headache | ||
| pill_id = | | pill_id = | ||
| routes = Oral | | routes = Oral | ||
| Line 21: | Line 21: | ||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Triptans]] | |||
[[Category:NSAIDs]] | |||
[[Category:Antimigraine agents]] | |||
[[Category:Fixed-dose combinations]] | |||